APA (7th ed.) Citation

Y, L., Y, X., C, G., Y, Z., J, Z., S, Z., . . . B, W. (2020). Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience. Dove Medical Press.

Chicago Style (17th ed.) Citation

Y, Li, et al. Comparative Treatment Patterns and Outcomes of Fulvestrant Versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience. Dove Medical Press, 2020.

MLA (8th ed.) Citation

Y, Li, et al. Comparative Treatment Patterns and Outcomes of Fulvestrant Versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience. Dove Medical Press, 2020.